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INTRODUCTION
Post-translational modifications of histone proteins play critical roles in DNArelated processes such as gene regulation, DNA repair and replication (4) (5) (6) . One highly conserved core modification is methylation of lysine 79 of histone H3 (H3K79) by the Dot1 family of histone methyltransferases. In contrast to yeast, flies, and humans, the protozoan parasite Trypanosoma brucei expresses two Dot1-like proteins that methylate histone H3K76, the T. brucei counterpart of H3K79. DOT1A is an essential enzyme, whereas DOT1B is dispensable for normal growth but is essential for the differentiation of bloodstream form to procyclic (insect-stage) trypanosomes (1) . Furthermore, DOT1B is involved in the tight repression and switching of telomeric Variant Surface Glycoprotein (VSG) gene expression site promoters (7;8) , indicating a role for DOT1B in antigenic variation of this parasite (9;10).
DOT1A and DOT1B most likely exert their different functions by differentially affecting the methylation state of H3K76. H3K76me2 and K76me3 appear to be the predominant H3K76 methylation states in T. brucei (1) . Immunostaining experiments revealed that H3K76me3 is constitutively detectable throughout the cell cycle, whereas H3K76me2 is restricted to mitosis (1) . Genetic studies suggest that DOT1B is responsible for H3K76 trimethylation because inactivation of DOT1B results in loss of H3K76me3 and an increase in H3K76me2 (1) . RNAimediated depletion of the essential DOT1A protein results in a partial decrease in H3K76me2 (1) , indicating that DOT1A may be responsible for the H3K76me2 peak in M phase.
To determine how the H3K76 methylation pattern is controlled in vivo, it is important to understand the substrate specificities of the two DOT1 enzymes and how they can be regulated. Dot1 enzymes recognize a part of H3 on the nucleosome surface that is in close proximity to histone H4 and DNA and they therefore most likely interact with a very complex binding surface. In vitro studies on Dot1 proteins to determine their enzymatic properties are complicated by the lack of activity of Dot1 towards free histone H3 and short peptides, and its weak activity towards reconstituted nucleosome substrates (1;11-13) . Interestingly, DOT1B could efficiently trimethylate H3K76-dimethylated native chromatin isolated from DOT1B knock-out trypanosomes in vitro (1) . However, whether DOT1B requires prior dimethylation of H3K76 by DOT1A remained unknown. Since DOT1A is an essential enzyme it is currently not possible to purify native chromatin substrates lacking H3K76 methylation from T. brucei for in vitro studies. To circumvent these problems, we used a heterologous expression system in Saccharomyces cerevisiae to investigate the activities and substrate specificities of DOT1A and DOT1B.
RESULTS AND DISCUSSION

Characterization of the activity of DOT1A and DOT1B in yeast
To investigate the activity of DOT1A and DOT1B, they were expressed individually in dot1Δ yeast strains lacking endogenous H3K79 methylation. Quantitative mass spectrometry (MS) and immunoblot analysis using antibodies specific for the TAP tag and mono-, di-, and trimethylated H3K79 showed that DOT1A and DOT1B were expressed ( Fig. S1 ) and that they very efficiently methylated H3K79 in yeast ( Fig. 1 A-D) . The highly conserved GxGxG motif ( Fig. 1A-B ) is essential for catalytic activity of Dot1 enzymes (2;14;15) . Catalytic mutants of DOT1A and DOT1B in which the central glycine of the GxGxG motif was mutated to arginine (DOT1A-G138R and DOT1B-G121R) showed no H3K79 methylation ( Fig. 1D ). We note that the expression of DOT1B-G121R was somewhat reduced ( Fig. S1 ). Interestingly, although DOT1A and DOT1B both methylated the vast majority of H3 in yeast, they showed a very distinct methylation pattern. DOT1A expression resulted in abundant H3K79me2 (Fig. 1C ), which is in agreement with the observations in T. brucei (1) . Expression of DOT1B resulted in abundant H3K79me3 (Fig. 1C ), confirming that DOT1B is responsible for trimethylation of H3K76 in T. brucei (1) . The nearly complete absence of H3K79me1 and H3K79me2 suggests that DOT1B more efficiently converts the lower methylation states into higher methylation states than ScDot1. Importantly, our results show that DOT1B could trimethylate H3K79 without prior dimethylation of H3K79 by DOT1A. How this impinges on the regulation of H3K76 methylation in T. brucei is discussed below.
H2B ubiquitination enhances methylation by DOT1A
Having established an expression system for DOT1A and DOT1B that recapitulates the properties of the enzymes in T. brucei, we took advantage of yeast genetics to investigate the possible modes of regulation of H3K76 methylation. In yeast and humans, ubiquitination of a C-terminal lysine on H2B (H2Bub) by the ubiquitin ligase Bre1 stimulates the activity of Dot1 (2;13;16-23). The molecular mechanism of this activation is unknown but the positive effect of H2Bub on the activity of human Dot1 does not require additional factors (13) . Therefore, we first asked whether methylation by TbDOT1 in yeast is affected by ubiquitination of H2BK123 (H2BK123ub). For that purpose, DOT1A and DOT1B were expressed in dot1Δbre1Δ cells, which lack endogenous H3K79 methylation and H2BK123ub. In this bre1Δ background, ScDot1 showed less H3K79me3 and more H3K79me1 than in wild-type cells ( Fig. 1E ), confirming the slow accumulation of methylation in the absence of H2BK123ub (2). The DOT1A activity was similarly affected by H2BK123ub albeit somewhat less than ScDot1. In contrast, DOT1B showed only a subtle increase in H3K79me2 and H3K79me1 in bre1Δ cells, indicating a minor effect of H2BK123ub on this enzyme ( Fig. 1E ). Thus chromatin ubiquitination can differentially affect the activity of T. brucei DOT1 enzymes in yeast.
DOT1A and DOT1B do not require the tail of histone H4
The negatively charged C-terminus of ScDot1 directly binds to a positively charged patch on the N-terminal tail of histone H4 in vitro and this interaction is required for full activity of ScDot1 in vivo (24;25) . Many of the positively charged residues on the H4 tail are conserved between yeast and trypanosomes, although the overall sequence of the tail is less conserved than that of the core ( Fig. 2A ). ScDot1 also binds to nucleosomes via its N-terminal domain in vitro (12;25) . Interestingly, DOT1A and DOT1B lack the known chromatin-binding domains ( Fig.  1A ), indicating that they have different targeting mechanisms or perhaps lack specific targeting mechanisms, the latter of which would be in line with their global activity in T. brucei (1) . Each canonical histone protein in yeast is encoded by only two genes, which offers the possibility to delete one copy and make mutations in the remaining copy. Using this possibility, we investigated the activity of DOT1A and DOT1B in yeast cells lacking the tail of histone H4 (H4Δ4-19; Fig. 2A ). In agreement with previous findings (24;25) , in these cells the activity of ScDot1 was severely reduced compared to wild-type cells, as indicated by the loss of H3K79me3 and H3K79me2 (Fig. 2B ). However, H3K79 methylation by DOT1A and DOT1B was not or only slightly reduced in cells expressing H4Δ4-19 as compared to wild type cells ( Fig. 2B ). Therefore, DOT1A and DOT1B did not require interactions with the H4 tail for efficient methylation in yeast.
The context of H3K79 influences the activity of DOT1B
There are several amino acid differences between trypanosome and yeast histone H3, in particular in the N-terminal tail and the sequence surrounding H3K76/H3K79 (Fig. 3A) . Our results show that DOT1A and DOT1B methylate H3K79 despite the divergent flanking sequence ( Fig. 1 ). To more closely mimic the T. brucei H3 protein substrate we replaced the yeast H3K79 flanking sequence (see the box in Fig. 3A ) with the trypanosome H3K76 flanking sequence (Fig.  3A,B ). The activity of DOT1A, DOT1B and ScDot1 towards the chimeric histone H3 in vivo was determined by immunoblot analysis using antibodies specific for TbH3K76me2 and TbH3K76me3, which were raised against methylated TbH3K76 peptides that are identical to the chimeric protein (1), although the lysine residue is still at position 79 in yeast. Antibodies against H3K76me1 are currently not available. DOT1A generated H3K76me2 and low levels of H3K76me3 (Fig. 3C ). This is similar to the activity of DOT1A towards wild-type yeast H3K79 (Fig. 1) , even though yeast H3K79me and T. brucei H3K76me blots cannot be directly compared in a quantitative manner. In contrast, DOT1B expression resulted in undetectable H3K76me3 and low H3K76me2 levels (Fig. 3C ). ScDot1 was unable to di-, and trimethylate the chimeric substrate (Fig. 3C ). To determine whether DOT1B requires prior methylation of the chimeric H3 protein, DOT1A and DOT1B were co-expressed. This, however, did not result in detectable H3K76me3. Therefore, DOT1B was unable to efficiently methylate the chimeric H3 protein, even when H3K76me2 was present (Fig. 3D ). We expect that in the context of the full yeast nucleosome, the T. brucei K76 region may adopt an unusual structure, even though the flanks of the loop are unchanged, and that DOT1B is more sensitive to the structural change.
Implications for regulation of histone methylation by DOT1A and DOT1B in T. brucei
To understand the cell-cycle related functions of DOT1A and the role of DOT1B in control of VSG expression sites, it is important to determine the enzymatic properties and modes of regulation of these enzymes. Unfortunately, methods that have been used for other Dot1 proteins can not be applied to the TbDOT1 enzymes. Human Dot1L has been well characterized by analysis of the activity of recombinant Dot1L towards defined reconstituted recombinant chromatin substrates or purified yeast chromatin templates (13;26-28). Attempts to reconstitute trypanosome chromatin have failed so far and one of the two DOT1 proteins is essential, precluding the possibility to purify nucleosomes with unmodified H3K76 from DOT1-deficient parasites (1) . The enzymatic properties of yeast Dot1 have been best characterized by in vivo manipulation of the single yeast Dot1 enzyme using genetic tools (2;29). Since DOT1A is essential, a similar genetic approach is not possible for trypanosomes (1) . To circumvent these restrictions, we developed a heterologous expression system. Heterologous expression has previously successfully been applied for characterization of many other proteins (e.g. see 30;31;32;33). One possible limitation of heterologous expression is that the T. brucei DOT1 proteins expressed in yeast may lack their putative natural binding partners or may interact with unknown yeast proteins. Other approaches have similar intrinsic limitations, however. The activity of DOT1 proteins in their native environment in trypanosomes may also be influenced by putative interactions with additional factors and in in vitro studies (if developed in the future) it is possible that critical components or conditions are missing. We note that the TbDOT1 proteins are mainly composed of a conserved methyltransferase core domain and lack the domains found in yeast or human Dot1 known to be involved in protein-and DNA-interactions ( Fig. 1) . Furthermore, the observed activities of DOT1A and DOT1B in yeast are in agreement with our previous observations in T. brucei (1) .
Our characterization of the T. brucei Dot1 enzymes in yeast showed that DOT1A and DOT1B have distinct catalytic properties. Therefore, regulation of the degree of histone methylation can be achieved by differential regulation of the two enzymes, something that is not possible in yeast or humans where a single Dot1 enzyme is present. That DOT1B can di-and trimethylate H3K79 in the absence of prior H3K79 methylation by DOT1A ( Fig. 1) has implications for the regulation of DOT1B to establish the appearance of H3K76me2 during M phase. By immunostaining H3K76me3 is detectable throughout the T. brucei cell cycle, whereas H3K76me2 is undetectable from G1-G2 and restricted to M phase and cytokinesis (1) . Our new findings suggest that DOT1B is most likely inactive during S and M phase towards the newly deposited unmodified histones to allow dimethylation of unmethylated H3K76 by DOT1A in M phase (Fig. 4) . Briefly, our (1) . Here we show that DOT1B can methylate H3 in the absence of prior methylation by DOT1A (see Fig. 1 ). Details of the model are described in the text.
findings together with our previous observations, suggest 1) no or low activity of DOTA and DOT1B in S phase and G2, when new unmodified histones are present in the chromatin, 2) subsequent activation of DOT1A to dimethylate H3K76 on the new histones in M phase, and 3) activation of DOT1B after exit from M phase to convert lower H3K76 methyl forms including H3K76me2 to H3K76me3 (Fig. 4) . Alternatively, the H3K76 methyl state could be regulated by cell cycle-specific demethylases. However, no H3K76/K79 demethylases have been described to date and this model does not explain why DOT1A is present and why it is required for normal cell cycle progression.
Although the TbDOT1 proteins were not expressed in their native environment, our results offer some suggestions for possible mechanisms of regulation of H3K76 methylation in trypanosomes. For example, DOT1A activity was higher in yeast cells containing ubiquitinated H2B (Fig. 1E) . However, the specific histone cross talk between H2B and H3K79/K76 does probably not exist in T. brucei since the canonical H2B of T. brucei does not contain a lysine at the Cterminal tail, and K129 of the histone variant H2BV is not required for H3K76 methylation and most likely not ubiquitinated (34) . Therefore, the mechanism by which H2Bub affects Dot1 enzymes might be rather non-specific, for example by changing the chromatin structure and thereby altering access to the substrate lysine on the nucleosome core. Another possibility is that ubiquitination of another chromatin protein complements the role of H2Bub in T. brucei. This is not unlikely because it has recently been show that the exact structure of the ubiquitin moiety and its position on the nucleosome core are not critical for activation of human Dot1 (27;28) . Finally, our finding that the ScH4 tail is not required for activity of DOT1A or DOT1B suggests that H3K76 methylation by DOT1A and DOT1B is most likely not directly modulated by interactions of other chromatin proteins with the histone H4 tail, a mechanism that has been suggested for the yeast heterochromatin protein Sir3 (24;25;35) . For a full understanding of the possible mechanisms of regulation of DOT1A and DOT1B it will be important to develop new genetic and biochemical tools to determine the behavior of the two proteins in their native environment and in defined in vitro assays.
MATERIALS AND METHODS
Yeast strains and plasmids
Yeast cells were grown as described previously (2) . Strains and plasmids are described in Tables 1 and 2 .
Immunoblots and mass spectrometry
Histone methylation was analyzed by mass spectrometry and immunoblots as described previously (2) . Primary antibodies used for immunodetections: H3, H3K79me1, H3K79me2 and H3K79me3 (2), Pgk1 (Invitrogen, A-6457), TAP (Open Biosystems, CAB1001), HA (12CA5), H3K76me2 and H3K76me3 (1). 
CENTRP1DOT1sHATAP
CENHIS3hhf2Δ419HHT2 12 pFvL130 pFA6asHATAPKanMX 13 1. Plasmid pFvL261 was made by cloning the P GAL1 -DOT1Tcyc1 insert of pFvL18 into pRS314 (36) by homologous recombination in yeast. 2. Plasmids pCJ49 and pFF19 were made by amplification of the coding sequence fused to a C-terminal HA-tag of TbDOT1A and TbDOT1B respectively, into the SpeI and NotI sites of pFvL261. Point mutants were made by site-directed mutagenesis and verified by DNA sequencing. The TbDOT1A sequence differs at one position from the reference sequence (P187S caused by CCG to TCG codon change). 3. To make plasmid pFvL283, pCJ49 was digested with SnaBI and co-transformed with pFvL099/ pRS40CloNAT digested with AatII and BamHI to replace the TRP1 marker by the NatMX cassette. Plasmids pFvL99 and pFvL100 were made replacing the PacI-BsmI KanMX fragment of pRS400 by the PacI-BsmI fragment of pAG25 (NatMX) and pAG32 (HphMX), respectively (36;37). 4. pTW98-101 were made from pCJ49 and pFF19-21 by replacing the HA tag with a HA-TAP tag from pFvL212. 5. Plasmid pFvL23 was generated by cloning the 1.8 kb genomic DOT1 coding sequence into the EcoRI and BamHI sites of pBTM116 (38). 6. (29) 7. pFvL212 was made in two steps. First, pFvL211 was made by replacing the LEU2 region of pRS315-Str1 (39) with TRP1 of pRS304 (36) resulting in plasmid pFvL211. Second, a PCR fragment of pFvL130 containing a spacer-HA-TAP tag followed by the ADH1 terminator was cloned into pFvL211 to replace the DOT1 3' region. 8. pFF013 was made by cloning the NruI-NotI fragment from pFvL213 into the NruI-NotI site of pFvL018. 9. (29) 10. Plasmid pFvL30 was made by cloning the 2.7 kb EcoRI-XbaI HHT2HHF2 fragment of pMP3 into EcoRI-XbaI sites of pRS313 (36). 11. pFvL30-TbK76 was made by site-directed mutagenesis to replace the Sc sequence 74-IAKDFKTD-81 by the Tb sequence 71-VSGAQKEG-78. 12. pTW096 was made by site directed mutagenesis using overlap PCR to delete 4-GKGGKGLGKGGAKRHR-19 of histone H4 (HHF2) in plasmid pFvL30. 13. pFvL130 was made in two steps. First a 580 bp BamHI-SmaI TAP fragment of pBS1479 (40) was cloned into the pFA6a-GFP-KanMX6 vector (41) (4.1 kb BamHI-AscI fragment) to replace the GFP coding sequence by TAP (pFvL29). Second, a flexible spacer (GGSGGS) and 1xHA tag were cloned in front of the TAP tag by annealing two primers and cloning the double stranded DNA into the BamHI site of pFvL130.
